The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study

The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study

Abstract Background and Aim The association between biliary disorders with weight reduction enhanced by GLP-1RAs was observed frequently, nevertheless, the relative risk of the clinically relevant cholelithiasis was not specified clearly among different GLP-1RAs. Methods 308 patients with type 2 dia...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Ali Gameil, Elshahat Ali Ahmed Mohamed Yousef, Rehab Elsayed Marzouk, Mohamed H. Emara, Abeer H. Abdelkader, Rasha Ibrahim Salama
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Diabetology & Metabolic Syndrome
Subjects:
GLP1-receptor agonists
Relevant
Biliary
Cholelithiasis
Type 2 diabetes mellitus
Online Access:https://doi.org/10.1186/s13098-024-01526-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13098-024-01526-2

Similar Items